9 citations
,
January 2020 in “Postepy Dermatologii I Alergologii”
This review discusses the enigmatic nature of frontal fibrosing alopecia and reports no clinical results; the authors stress the need for further research.
14 citations
,
April 2017 in “American Journal of Transplantation”
This review examines nonmalignant skin toxicities from immunosuppressive and transplant-related medications, emphasizing the need for effective identification and management by care providers; it presents no new research findings.
1 citations
,
August 2021 in “Movement disorders clinical practice”
This case report describes the first documented occurrence of hemi-Isaac's syndrome or acquired neuromyotonia affecting only one side of the body, with symptoms improving after immunomodulatory treatment.
8 citations
,
January 2003 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”
This study describes three female cases of androgen-dependent diseases in myotonic dystrophy, suggesting that peripheral androgen response, rather than serum levels, may drive such conditions.
Bodyhair is more resilient than scalp hair due to different gene expressions and DHT sensitivity. Treatments like minoxidil and finasteride are used for hairloss, but they have varying effects on body and scalp hair.
A dental technician claims malocclusion causes pattern hairloss due to poor scalp circulation. Users debate this, noting treatments like finasteride, minoxidil, and microneedling focus on DHT and blood flow.
Switching from finasteride to dutasteride often causes increased hair shedding initially. Dutasteride is stronger but takes longer to show results, leading to concerns about worsening hairloss during the transition.
A 21-year-old is experiencing severe hairloss despite using finasteride and minoxidil, and plans to try dutasteride. Others share similar struggles and suggest various treatments like RU58841, spironolactone, and hair systems, while emphasizing the emotional impact of hairloss.
The conversation discusses hairloss treatments, focusing on the use of topical minoxidil, microneedling, finasteride, and dutasteride, while debating the role of testosterone and DHT in hairloss. It also touches on the potential liver health impacts of these treatments and the genetic sensitivity of hair follicles to androgens.